🎉 M&A multiples are live!
Check it out!

Polymed Valuation Multiples

Discover revenue and EBITDA valuation multiples for Polymed and similar public comparables like Gerresheimer, Fresenius, and Fresenius Medical Care.

Polymed Overview

About Polymed

Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, vascular access, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.


Founded

1995

HQ

India
Employees

2.7K+

Financials

LTM Revenue $192M

LTM EBITDA $53.0M

EV

$2.4B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Polymed Financials

Polymed has a last 12-month revenue of $192M and a last 12-month EBITDA of $53.0M.

In the most recent fiscal year, Polymed achieved revenue of $156M and an EBITDA of $48.0M.

Polymed expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Polymed valuation multiples based on analyst estimates

Polymed P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $127M $156M XXX XXX XXX
Gross Profit $55.3M $68.5M XXX XXX XXX
Gross Margin 44% 44% XXX XXX XXX
EBITDA $34.7M $48.0M XXX XXX XXX
EBITDA Margin 27% 31% XXX XXX XXX
Net Profit $16.7M $20.5M XXX XXX XXX
Net Margin 13% 13% XXX XXX XXX
Net Debt $13.4M $15.9M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Polymed Stock Performance

As of March 14, 2025, Polymed's stock price is INR 2214 (or $25).

Polymed has current market cap of INR 224B (or $2.6B), and EV of INR 213B (or $2.4B).

See Polymed trading valuation data

Polymed Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$2.4B $2.6B XXX XXX XXX XXX $0.38

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Polymed Valuation Multiples

As of March 14, 2025, Polymed has market cap of $2.6B and EV of $2.4B.

Polymed's trades at 12.7x LTM EV/Revenue multiple, and 46.0x LTM EBITDA.

Analysts estimate Polymed's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Polymed and 10K+ public comps

Polymed Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $2.4B XXX XXX XXX
EV/Revenue 13.3x XXX XXX XXX
EV/EBITDA 46.8x XXX XXX XXX
P/E 71.0x XXX XXX XXX
P/E/Growth 2.7x XXX XXX XXX
EV/FCF 414.2x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Polymed Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Polymed Valuation Multiples

Polymed's NTM/LTM revenue growth is 23%

Polymed's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $20K for the same period.

Over next 12 months, Polymed's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Polymed's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Polymed and other 10K+ public comps

Polymed Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 23% XXX XXX XXX XXX
EBITDA Margin 28% XXX XXX XXX XXX
EBITDA Growth 39% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 51% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $20K XXX XXX XXX XXX
S&M Expenses to Revenue 2% XXX XXX XXX XXX
G&A Expenses to Revenue 2% XXX XXX XXX XXX
R&D Expenses to Revenue 1% XXX XXX XXX XXX
Opex to Revenue 34% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Polymed Public Comps

See public comps and valuation multiples for Medical Supplies comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Ansell XXX XXX XXX XXX XXX XXX
Schott Pharma XXX XXX XXX XXX XXX XXX
Fresenius Medical Care XXX XXX XXX XXX XXX XXX
Fresenius XXX XXX XXX XXX XXX XXX
Gerresheimer XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Polymed M&A and Investment Activity

Polymed acquired  XXX companies to date.

Last acquisition by Polymed was  XXXXXXXX, XXXXX XXXXX XXXXXX . Polymed acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Polymed

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Polymed

When was Polymed founded? Polymed was founded in 1995.
Where is Polymed headquartered? Polymed is headquartered in India.
How many employees does Polymed have? As of today, Polymed has 2.7K+ employees.
Is Polymed publicy listed? Yes, Polymed is a public company listed on BOM.
What is the stock symbol of Polymed? Polymed trades under 531768 ticker.
When did Polymed go public? Polymed went public in 1996.
Who are competitors of Polymed? Similar companies to Polymed include e.g. Ansell, Schott Pharma, Fresenius Medical Care, Fresenius.
What is the current market cap of Polymed? Polymed's current market cap is $2.6B
What is the current revenue of Polymed? Polymed's last 12-month revenue is $192M.
What is the current EBITDA of Polymed? Polymed's last 12-month EBITDA is $53.0M.
What is the current EV/Revenue multiple of Polymed? Current revenue multiple of Polymed is 12.7x.
What is the current EV/EBITDA multiple of Polymed? Current EBITDA multiple of Polymed is 46.0x.
What is the current revenue growth of Polymed? Polymed revenue growth between 2023 and 2024 was 23%.
Is Polymed profitable? Yes, Polymed is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.